Back to investors
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.
Latest filing: 2026-06-30
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. runs FRAZIER LIFE SCIENCES MANAGEMENT, L.P. and currently holds 41 stock positions, which is fewer than the average of 230 among the investors we track. The portfolio is valued at approximately $4.59B. Their top holdings are MIRM, NAMS, ERAS, ARQT, TRVI. The top five represent 52.6% of reported portfolio weight. FRAZIER LIFE SCIENCES MANAGEMENT, L.P. ranks #N/A out of 1000 investors tracked by Alpha Score. In the most recent quarter, FRAZIER LIFE SCIENCES MANAGEMENT, L.P. initiated 3 new positions. They added to 7 existing positions. They trimmed 2 positions. Their current best-performing preview position is MNKD with returns of +73.88%.
Sign in to enable email alerts for this investor.
Showper page
41 stock holdings
| Holding | Weight | Avg Buy | Current | Return | Quarter Change |
|---|---|---|---|---|---|
 MIRM MIRUM PHARMACEUTICALS INC | 19.58% | $33.83 | $96.31 | +184.69% | Held |
 NAMS NEWAMSTERDAM PHARMA COMPANY | 13.35% | $15.80 | $27.87 | +76.39% | Added +6.76% |
 ERAS ERASCA INC | 9.96% | $3.59 | $17.63 | +391.09% | Added +1.22% |
 ARQT ARCUTIS BIOTHERAPEUTICS INC | 5.64% | $18.53 | $25.08 | +35.35% | Held |
 TRVI TREVI THERAPEUTICS INC | 4.04% | $2.53 | $17.96 | +609.88% | Trimmed -0.00% |
 KRYS KRYSTAL BIOTECH INC | 3.90% | $68.67 | $346.58 | +404.70% | Held |
 PHAT PHATHOM PHARMACEUTICALS INC | 2.95% | $12.42 | $8.87 | -28.58% | Held |
 PVLA PALVELLA THERAPEUTICS INC NE | 2.94% | $33.47 | $142.04 | +324.38% | Held |
 BBIO BRIDGEBIO PHARMA INC | 2.51% | $22.30 | $81.50 | +265.47% | Trimmed -55.10% |
 IRON DISC MEDICINE INC | 2.16% | $47.75 | $79.81 | +67.14% | Held |
Showing 1-10 of 41